expert opinion on investigational drugs

[1] Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease.

[2] targeting hypoxia inducible factors-1α as a novel therapy in fibrosis

[3] furan- and thiophene-2-carbonyl amino acid derivatives activate hypoxia-inducible factor via inhibition of factor inhibiting hypoxia-inducible factor-1

[4] targeting hypoxia inducible factors-1α as a novel therapy in fibrosis

[5] low-molecular-weight heparin reduces ventilation-induced lung injury through hypoxia inducible factor-1α in a murine endotoxemia model

[6] hypoxia inducible factors modify collagen i fibers in mda-mb-231 triple negative breast cancer xenografts

[7] Colorectal cancer risk in relation to hypoxia inducible factor-1α (Hif-1 α) and von hippel-lindau (Vhl) gene polymorphisms